Tempus AI Change in Accounts Receivable 2023-2025 | TEM
Tempus AI annual/quarterly change in accounts receivable history and growth rate from 2023 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
- Tempus AI change in accounts receivable for the quarter ending June 30, 2025 was $-0.049B, a 105.06% increase year-over-year.
- Tempus AI change in accounts receivable for the twelve months ending June 30, 2025 was $-0.207B, a 194.82% increase year-over-year.
- Tempus AI annual change in accounts receivable for 2024 was $-0.061B, a 730.77% increase from 2023.
- Tempus AI annual change in accounts receivable for 2023 was $-0.007B, a 10.44% decline from 2022.
- Tempus AI annual change in accounts receivable for 2022 was $-0.008B, a 0% decline from .
| Tempus AI Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2024 | $-61 |
| 2023 | $-7 |
| 2022 | $-8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.696B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.466B | 59.12 |
| Doximity (DOCS) | United States | $11.914B | 53.01 |
| Hims & Hers Health (HIMS) | United States | $9.534B | 78.11 |
| IRhythm Technologies (IRTC) | United States | $5.093B | 0.00 |
| Hinge Health (HNGE) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.663B | 39.16 |
| Privia Health (PRVA) | United States | $2.603B | 192.82 |
| Heartflow (HTFL) | $2.489B | 0.00 | |
| Enovis (ENOV) | United States | $1.740B | 9.20 |
| Phreesia (PHR) | United States | $1.681B | 0.00 |
| 10x Genomics (TXG) | United States | $1.669B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 28.24 |
| Schrodinger (SDGR) | United States | $1.428B | 0.00 |
| Azenta (AZTA) | United States | $1.388B | 60.58 |
| Clover Health Investments (CLOV) | United States | $1.292B | 0.00 |
| Claritev (CTEV) | United States | $1.115B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.660B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.568B | 0.00 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.347B | 0.00 |
| Carlsmed (CARL) | $0.333B | 0.00 | |
| TruBridge (TBRG) | United States | $0.293B | 51.40 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.137B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.119B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.086B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |